undefined

Daniela Marino

Co-founder and CEO of Cutiss, a Swiss late-stage techbio company developing personalized skin tissue therapies (NovoSkin) with CHF 100M+ raised largely without traditional VCs and currently advancing through late-stage clinical trials and regulatory pathways.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app